1.
FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis.
by Chung, Carolyn S
August 2012
Pediatrics, Vol.130(2), pp.e408-e414
2012

2.
Tolerable upper intake levels for trans fat, saturated fat, and cholesterol
by Trumbo, Paula R
Nutrition reviews, May 2011, Vol.69(5), pp.270-8

3.
FDA regulations regarding iodine addition to foods and labeling of foods containing added iodine.
by Trumbo, Paula R
September 2016
The American journal of clinical nutrition, Vol.104 Suppl 3, pp.864S-7S
2016

4.
Perchlorate consumption, iodine status, and thyroid function
by Trumbo, Paula R
Nutrition Reviews, January 2010, Vol.68(1), pp.62-66

5.
Systematic review of the evidence for an association between sugar‐sweetened beverage consumption and risk of obesity
by Trumbo, Paula R
Nutrition Reviews, September 2014, Vol.72(9), pp.566-574

6.
Qualified health claim for whole-grain intake and risk of type 2 diabetes: an evidence-based review by the US Food and Drug Administration
by Yamini, Sedigheh
Nutrition Reviews, 2016, Vol. 74(10), pp.601-611

7.
D ietary reference intakes: cases of appropriate and inappropriate uses
by Trumbo, Paula R
Nutrition Reviews, October 2013, Vol.71(10), pp.657-664

8.
How the US Food and Drug Administration evaluates the scientific evidence for health claims
by Ellwood, Kathleen C
Nutrition Reviews, February 2010, Vol.68(2), pp.114-121

9.
Evidence needed to inform the next dietary reference intakes for iodine.
by Trumbo, Paula R
November 2013
Advances in nutrition (Bethesda, Md.), Vol.4(6), pp.718-722
2013

10.
Comment on “Nutrient reference values for bioactives: new approaches needed? A conference report” (European Journal of Nutrition, April 2013, Volume 52, Issue 1 Supplement, pp 1–9)...
by Trumbo, Paula
European Journal of Nutrition, 2013, Vol.52(5), pp.1541-1541

11.
Comparison of 2 methods for estimating the prevalences of inadequate and excessive iodine intakes.
by Juan, Wenyen
The American journal of clinical nutrition, September 2016, Vol.104 Suppl 3, pp.888S-97S

12.
Challenges with using chronic disease endpoints in setting dietary reference intakes
by Trumbo, Paula R
Nutrition Reviews, August 2008, Vol.66(8), pp.459-464

13.
Biomarkers in nutrition: new frontiers in research and application
by Combs, Gerald F.
Annals of the New York Academy of Sciences, March 2013, Vol.12781(1), pp.1-10

14.
The level of evidence for permitting a qualified health claim: FDA's review of the evidence for selenium and cancer and vitamin E and heart disease
by Trumbo, Paula R
The Journal of nutrition, February 2005, Vol.135(2), pp.354-6

15.
Supplemental Calcium and Risk Reduction of Hypertension, Pregnancy‐Induced Hypertension, and Preeclampsia: An Evidence‐Based Review by the US Food and Drug Administration
by Trumbo, Paula R.
Nutrition Reviews, February 2007, Vol.65(2), pp.78-87

16.
Are there adverse effects of lycopene exposure?
by Trumbo, Paula R
The Journal of nutrition, August 2005, Vol.135(8), pp.2060S-1S

17.
Chromium Picolinate Intake and Risk of Type 2 Diabetes: An Evidence‐Based Review by the United States Food and Drug Administration
by Trumbo, Paula R.
Nutrition Reviews, August 2006, Vol.64(8), pp.357-363

18.
Iodine.
by Zimmermann, Michael
Advances in nutrition (Bethesda, Md.), March 1, 2013, Vol.4(2), pp.262-264

19.
Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for he...
by Trumbo, Paula R
The American journal of clinical nutrition, November 2006, Vol.84(5), pp.971-4

20.
Summary of an NIH workshop to identify research needs to improve the monitoring of iodine status in the United States and to inform the DRI.
by Swanson, Christine A
The Journal of nutrition, June 2012, Vol.142(6), pp.1175S-85S
